Studies using an ex vivo skin explant model have demonstrated that Langerhans cells (LCs), a specialized skin-resident DC subset, inefficiently promote trans-enhancement as immature LCs, but stimulation with TLR1/TLR2 agonists promotes LC maturation, and significantly increases their ability to trans-enhance HIV infection [129]. Here, TLR2 is linked to HIV infectious disease.